# Ulta Beauty, Inc.: financial statements, quarterly

ULTA · Nasdaq · CIK 1403568 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/ulta.md) · [Financials](/companies/ulta/financials.md) · [Filings](/companies/ulta/filings.md) · [Insiders](/companies/ulta/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ulta/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,489](/filings/0001558370-24-016048.md) | [3,554 d](/filings/0001104659-26-035243.md) | [2,726](/filings/0001558370-25-008243.md) | [2,552](/filings/0001558370-25-011804.md) | [2,530](/filings/0001104659-25-118458.md) | [3,488 d](/filings/0001104659-26-035243.md) | [2,848](/filings/0001104659-26-069491.md) | [2,788](/filings/0001104659-26-102442.md) | [2,858](/filings/0001104659-25-118458.md) | [3,898 d](/filings/0001104659-26-035243.md) | [3,164](/filings/0001104659-26-069491.md) | [3,036](/filings/0001104659-26-102442.md) |
| Cost of revenue | $m | [1,497](/filings/0001558370-24-016048.md) | [2,214 d](/filings/0001104659-26-035243.md) | [1,656](/filings/0001558370-25-008243.md) | [1,574](/filings/0001558370-25-011804.md) | [1,524](/filings/0001104659-25-118458.md) | [2,154 d](/filings/0001104659-26-035243.md) | [1,734](/filings/0001104659-26-069491.md) | [1,697](/filings/0001104659-26-102442.md) | [1,702](/filings/0001104659-25-118458.md) | [2,415 d](/filings/0001104659-26-035243.md) | [1,896](/filings/0001104659-26-069491.md) | [1,849](/filings/0001104659-26-102442.md) |
| Gross profit | $m | [992](/filings/0001558370-24-016048.md) | [1,341 d](/filings/0001104659-26-035243.md) | [1,070](/filings/0001558370-25-008243.md) | [978](/filings/0001558370-25-011804.md) | [1,006](/filings/0001104659-25-118458.md) | [1,334 d](/filings/0001104659-26-035243.md) | [1,114](/filings/0001104659-26-069491.md) | [1,092](/filings/0001104659-26-102442.md) | [1,156](/filings/0001104659-25-118458.md) | [1,484 d](/filings/0001104659-26-035243.md) | [1,268](/filings/0001104659-26-069491.md) | [1,187](/filings/0001104659-26-102442.md) |
| Selling, general and administrative | $m | [661](/filings/0001558370-24-016048.md) | [820 d](/filings/0001104659-26-035243.md) | [666](/filings/0001558370-25-008243.md) | [645](/filings/0001558370-25-011804.md) | [682](/filings/0001104659-25-118458.md) | [816 d](/filings/0001104659-26-035243.md) | [711](/filings/0001104659-26-069491.md) | [742](/filings/0001104659-26-102442.md) | [841](/filings/0001104659-25-118458.md) | [1,003 d](/filings/0001104659-26-035243.md) | [815](/filings/0001104659-26-069491.md) | [803](/filings/0001104659-26-102442.md) |
| Operating income | $m | [327](/filings/0001558370-24-016048.md) | [517 d](/filings/0001104659-26-035243.md) | [401](/filings/0001558370-25-008243.md) | [329](/filings/0001558370-25-011804.md) | [319](/filings/0001104659-25-118458.md) | [516 d](/filings/0001104659-26-035243.md) | [402](/filings/0001104659-26-069491.md) | [345](/filings/0001104659-26-102442.md) | [309](/filings/0001104659-25-118458.md) | [477 d](/filings/0001104659-26-035243.md) | [448](/filings/0001104659-26-069491.md) | [380](/filings/0001104659-26-102442.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [80.2](/filings/0001558370-24-016048.md) | [126 d](/filings/0001104659-26-035243.md) | [94.7](/filings/0001558370-25-008243.md) | [81.2](/filings/0001558370-25-011804.md) | [78.0](/filings/0001104659-25-118458.md) | [125 d](/filings/0001104659-26-035243.md) | [99.6](/filings/0001104659-26-069491.md) | [84.8](/filings/0001104659-26-102442.md) | [73.4](/filings/0001104659-25-118458.md) | [116 d](/filings/0001104659-26-035243.md) | [107](/filings/0001104659-26-069491.md) | [91.9](/filings/0001104659-26-102442.md) |
| Net income | $m | [249](/filings/0001558370-24-016048.md) | [394 d](/filings/0001104659-26-035243.md) | [313](/filings/0001104659-25-118458.md) | [253](/filings/0001104659-25-118458.md) | [242](/filings/0001104659-25-118458.md) | [393 d](/filings/0001104659-26-035243.md) | [305](/filings/0001104659-26-102442.md) | [261](/filings/0001104659-26-102442.md) | [231](/filings/0001104659-25-118458.md) | [357 d](/filings/0001104659-26-035243.md) | [340](/filings/0001104659-26-102442.md) | [282](/filings/0001104659-26-102442.md) |
| Diluted EPS | $ per share | [5.07](/filings/0001558370-24-016048.md) | not reported | [6.47](/filings/0001558370-25-008243.md) | [5.30](/filings/0001558370-25-011804.md) | [5.14](/filings/0001104659-25-118458.md) | not reported | [6.70](/filings/0001104659-26-069491.md) | [5.78](/filings/0001104659-26-102442.md) | [5.14](/filings/0001104659-25-118458.md) | not reported | [7.74](/filings/0001104659-26-069491.md) | [6.55](/filings/0001104659-26-102442.md) |
| Basic EPS | $ per share | [5.09](/filings/0001558370-24-016048.md) | not reported | [6.51](/filings/0001558370-25-008243.md) | [5.32](/filings/0001558370-25-011804.md) | [5.16](/filings/0001104659-25-118458.md) | not reported | [6.72](/filings/0001104659-26-069491.md) | [5.80](/filings/0001104659-26-102442.md) | [5.16](/filings/0001104659-25-118458.md) | not reported | [7.78](/filings/0001104659-26-069491.md) | [6.57](/filings/0001104659-26-102442.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [122](/filings/0001558370-24-016048.md) | [767](/filings/0001558370-25-003810.md) | [525](/filings/0001558370-25-008243.md) | [414](/filings/0001558370-25-011804.md) | [178](/filings/0001104659-25-118458.md) | [703](/filings/0001104659-26-035243.md) | [455](/filings/0001104659-26-069491.md) | [243](/filings/0001104659-26-102442.md) | [205](/filings/0001104659-25-118458.md) | [424](/filings/0001104659-26-102442.md) | [166](/filings/0001104659-26-069491.md) | [158](/filings/0001104659-26-102442.md) |
| Current assets | $m | [2,792](/filings/0001558370-24-016048.md) | [2,837](/filings/0001558370-25-003810.md) | [2,761](/filings/0001558370-25-008243.md) | [2,799](/filings/0001558370-25-011804.md) | [2,955](/filings/0001104659-25-118458.md) | [3,029](/filings/0001104659-26-035243.md) | [2,940](/filings/0001104659-26-069491.md) | [3,069](/filings/0001104659-26-102442.md) | [3,371](/filings/0001104659-25-118458.md) | [3,144](/filings/0001104659-26-102442.md) | [3,022](/filings/0001104659-26-069491.md) | [3,069](/filings/0001104659-26-102442.md) |
| Total assets | $m | [5,595](/filings/0001558370-24-016048.md) | [5,707](/filings/0001558370-25-003810.md) | [5,632](/filings/0001558370-25-008243.md) | [5,737](/filings/0001558370-25-011804.md) | [5,958](/filings/0001104659-25-118458.md) | [6,002](/filings/0001104659-26-035243.md) | [5,987](/filings/0001104659-26-069491.md) | [6,631](/filings/0001104659-26-102442.md) | [7,012](/filings/0001104659-25-118458.md) | [6,999](/filings/0001104659-26-102442.md) | [6,895](/filings/0001104659-26-069491.md) | [6,964](/filings/0001104659-26-102442.md) |
| Current liabilities | $m | [1,837](/filings/0001558370-24-016048.md) | [1,658](/filings/0001558370-25-003810.md) | [1,573](/filings/0001558370-25-008243.md) | [1,591](/filings/0001558370-25-011804.md) | [1,816](/filings/0001104659-25-118458.md) | [1,779](/filings/0001104659-26-035243.md) | [1,764](/filings/0001104659-26-069491.md) | [2,201](/filings/0001104659-26-102442.md) | [2,538](/filings/0001104659-25-118458.md) | [2,224](/filings/0001104659-26-102442.md) | [2,304](/filings/0001104659-26-069491.md) | [2,281](/filings/0001104659-26-102442.md) |
| Total liabilities | $m | [3,566](/filings/0001558370-24-016048.md) | [3,428](/filings/0001558370-25-003810.md) | [3,331](/filings/0001558370-25-008243.md) | [3,389](/filings/0001558370-25-011804.md) | [3,629](/filings/0001104659-25-118458.md) | [3,513](/filings/0001104659-26-035243.md) | [3,556](/filings/0001104659-26-069491.md) | [4,027](/filings/0001104659-26-102442.md) | [4,379](/filings/0001104659-25-118458.md) | [4,196](/filings/0001104659-26-102442.md) | [4,314](/filings/0001104659-26-069491.md) | [4,320](/filings/0001104659-26-102442.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [195](/filings/0001558370-24-016048.md) | not reported | not reported | not reported | [200](/filings/0001104659-25-118458.md) | not reported | not reported | [289](/filings/0001104659-26-102442.md) | [552](/filings/0001104659-25-118458.md) | [62.3](/filings/0001104659-26-102442.md) | [145](/filings/0001104659-26-069491.md) | [340](/filings/0001104659-26-102442.md) |
| Shareholders' equity | $m | [2,029](/filings/0001558370-24-016048.md) | [2,279](/filings/0001104659-26-035243.md) | [2,301](/filings/0001104659-25-118458.md) | [2,348](/filings/0001104659-25-118458.md) | [2,329](/filings/0001104659-25-118458.md) | [2,488](/filings/0001104659-26-102442.md) | [2,430](/filings/0001104659-26-102442.md) | [2,604](/filings/0001104659-26-102442.md) | [2,633](/filings/0001104659-25-118458.md) | [2,803](/filings/0001104659-26-102442.md) | [2,581](/filings/0001104659-26-102442.md) | [2,644](/filings/0001104659-26-102442.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(70.8) d](/filings/0001558370-24-016048.md) | [1,118 d](/filings/0001104659-26-035243.md) | [159](/filings/0001558370-25-008243.md) | [200 d](/filings/0001558370-25-011804.md) | [(56.8) d](/filings/0001104659-25-118458.md) | [1,037 d](/filings/0001104659-26-035243.md) | [220](/filings/0001104659-26-069491.md) | [96.5 d](/filings/0001104659-26-102442.md) | [5.6 d](/filings/0001104659-25-118458.md) | [1,181 d](/filings/0001104659-26-035243.md) | [262](/filings/0001104659-26-069491.md) | [120 d](/filings/0001104659-26-102442.md) |
| Capital expenditure | $m | [106 d](/filings/0001558370-24-016048.md) | [124 d](/filings/0001104659-26-035243.md) | [91.0](/filings/0001558370-25-008243.md) | [95.3 d](/filings/0001558370-25-011804.md) | [114 d](/filings/0001104659-25-118458.md) | [73.9 d](/filings/0001104659-26-035243.md) | [79.0](/filings/0001104659-26-069491.md) | [77.0 d](/filings/0001104659-26-102442.md) | [87.3 d](/filings/0001104659-25-118458.md) | [192 d](/filings/0001104659-26-035243.md) | [58.3](/filings/0001104659-26-069491.md) | [81.3 d](/filings/0001104659-26-102442.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [282 d](/filings/0001558370-24-016048.md) | [155 d](/filings/0001104659-26-035243.md) | [289](/filings/0001558370-25-008243.md) | [212 d](/filings/0001558370-25-011804.md) | [264 d](/filings/0001104659-25-118458.md) | [238 d](/filings/0001104659-26-035243.md) | [370](/filings/0001104659-26-069491.md) | [109 d](/filings/0001104659-26-102442.md) | [225 d](/filings/0001104659-25-118458.md) | [197 d](/filings/0001104659-26-035243.md) | [545](/filings/0001104659-26-069491.md) | [248 d](/filings/0001104659-26-102442.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.4](/filings/0001558370-23-019393.md) | [50.5](/filings/0001558370-24-008777.md) | [49.8](/filings/0001558370-24-012542.md) | [49.2](/filings/0001558370-24-016048.md) | [48.4](/filings/0001558370-25-008243.md) | [47.7](/filings/0001558370-25-011804.md) | [47.1](/filings/0001104659-25-118458.md) | [45.5](/filings/0001104659-26-069491.md) | [45.1](/filings/0001104659-26-102442.md) | [44.9](/filings/0001104659-25-118458.md) | [44.0](/filings/0001104659-26-069491.md) | [43.1](/filings/0001104659-26-102442.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,757,471 at 2026-08-24, from the cover of the [10-Q filed 2026-08-27](/filings/0001104659-26-102442.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.